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ment of late stent failure was observed in this new dual therapy
COMBO DES up to 3 years.
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BACKGROUND In ST elevation myocardial infarction (STEMI) pa-
tients undergoing primary percutaneous coronary intervention (PCI),
treatment with a mesh-covered bare metal stents instead of con-
ventional stents could potentially improve outcomes. Currently
several clinically available drug eluting stents (DES) have similar,
dense-strut structure. Therefore we compared early outcomes of
patients revascularized with dense (dsDES) and regular structure
DES.METHODS In this multicenter, prospective, web-based registry we
enrolled consecutive patients presenting with anterior wall STEMI
treated with primary PCI and single stent implantation. Dense struc-
ture DES (dsDES) were deﬁned as stents with cell area less than 1 mm2
in the 3.0 x 18 mm stent and consisted of either Alex (Balton, Poland)
or Biomatrix (Biosensors, Switzerland). Otherwise, regular structure
DES consisted of Xience V (Abbott, USA), Resolute Integrity (Med-
tronic, USA) and Promus Element (Boston Scientiﬁc). In-hospital
temporal CK-MB mass release and ﬁnal ejection fractions were
evaluated.
RESULTS In total 1777 patients were included. Dense structure DES
were implanted in 1569 patients, whereas regular DES in 208. The
baseline group demographic and clinical characteristics were well-
balanced. The baseline (248  2699 vs. 162  2164 ng/ml; p¼0,60)
and 12 hour (681  2699 vs. 1366  7659 vs. ng/ml; p¼0,6) CKMB
release after PCI was similar between dense and regular structure
DES. At 24 (345  3300 vs. 1104  6701 ng/ml; p¼0.16) and 48
hours (38  38 vs. 986  8186 p¼0.11) there was a trend toward
lower CKMB values in the dsDES when compared to DES. The area
under curve of CKMB temporal release was not different between
dense and regular structure DES (3918  3871 vs. 4084  3948
p¼0.50.). There was also no difference in left ventricle ejection
fraction (42.6  10 vs. 41.8  11 p¼0.31) or major adverse clinical
events.
CONCLUSIONS In this large registry of patients undergoing primary
PCI, implantation of a dense structure DES was not associated with
higher level of cardioprotection as expressed by lower cardiac enzyme
release in patients undergoing primary PCI.
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BACKGROUND Primary percutaneous coronary intervention (PCI) in
ST Segment Elevation Myocardial Infarction (STEMI) is associated
with greater risk of late stent malapposition and stent thrombosis. The
aim was to assess changes in stent apposition, strut coverage, 1 year
after Resolute Integrity stent implantation in patients with STEMI
treated with primary PCI.
METHODS Seventy-four STEMI patients treated with primary PCI
were examined with optical coherence tomography (OCT) of the
stented segment within 72 hours after primary PCI and after 1 year.
RESULTS A total of 18,875 struts were analyzed post-PCI and 19,208
struts after 1 year. Acute malapposition was seen in 59 patients
(79.7%) and in 21 patients (28.4%) after 1 year. Malapposition was
resolved in 41 patients (69.5%) and late acquired in 3 patients (14.3%).
The percentage of malapposed struts was 5.8% post-PCI and 0.6%
(p<0.001) after 1 year. After 1 year, 88.7% stent struts were covered
and the median neointimal thickness was 120.0 (100 - 60) mm. The
percentage of covered struts was lower in patients with post-PCI
malapposition (84.9% vs. 95.6%, p¼0.004). Complete strut coverage
was seen in 9.5% of patients after 1 year. Thrombus was present in
90.5% post-PCI (red 208.3 quadrants, white 21.4 quadrants, and mixed
57.9 quadrants).
CONCLUSIONS Complete strut coverage was only seen in 1 out of 10
patients. Strut coverage was lower in patients with post-PCI
malapposition.
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